Multifactorial Approach to Predicting Resistance to Anthracyclines

Abstract

Given its high NPV, the A-Score could become, if further validated, a useful clinical tool to identify those patients who do not benefit from anthracyclines and could therefore be spared the non-negligible adverse effects.